University of Zurich
Zurich, 8001, Switzerland
NCT Number: NCT03654092
The aim of this study is to assess the effectiveness of a home-based exercise training program in COPD patients who did not participate in an inpatient or outpatient rehabilitation program within the last 2 years.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Zurich, 8001, Switzerland
Exercise training is an important component of pulmonary rehabilitation (PR) the management of chronic obstructive pulmonary disease (COPD) and numerous trials have shown large improvements in health-related quality of life (HRQoL) and exercise capacity in persons with COPD. However, the great majority of patients who would benefit from PR never follow such a program. Moreover, many COPD patients are either not instructed to exercise at all or fail to adhere to exercise training at home after completing PR.
This study evaluates a newly developed exercise training program that requires minimal equipment (i.e., only a chair and elastic bands) and can be easily implemented long-term in the patient's home-setting.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Home-based exercise training program that requires only minimal equipment, and is individually adaptable to the participant's exercise level (6 times per week; 15-20 min; 38 exercise cards and one interactive training agenda booklet). After randomization, a health care professional (HOMEX coach) will visit the intervention group participants at their home to set up the training location, to instruct the exercises and to establish individualized goals. Follow-up visits are planned after 3 and 8-9 weeks. Regular telephone calls will be conducted by the same HOMEX coach to motivate the patients, to discuss training progress and concrete benefits and barriers, and to adapt goals and the training program. Additional intervention elements are that a relative or friend is involved as a "sparring" partner to support the participant. The general practitioner is informed about the participation of his/her patient in the intervention.
Time frame: Change from baseline to 12 months
Dyspnea domain of the CRQ; 5 questions; 7-point Likert-type scale ranging from 1 (most severe dyspnea) to 7 (no dyspnea)
Time frame: Change from baseline to 3, 6 and 12 months
Dyspnea domain of the CRQ; 5 questions; 7-point Likert-type scale ranging from 1 (most severe dyspnea) to 7 (no dyspnea)
Time frame: Change from baseline to 12 months
Total distance in meters walked by the patient during timed six minutes. The 6MWT will be conducted twice (the better result will be used) and according to the American Thoracic Society (ATS) guidelines
Time frame: Change from baseline to 12 months
The number of repetitions that the patient completes the full sit-to-stand movement from a standard chair (i.e. standing up from a chair and sitting down again) during one minute
Time frame: Change from baseline to 12 months
Remaining domains of the CRQ (besides the dyspnea domain): Domains fatigue, emotional function and mastery. The total CRQ contains 20 questions responded to on a 7-point Likert-type scale, ranging from 1 to 7 with lower scores indicating worse HRQoL, loading on the domains dyspnea, fatigue, emotional and mastery
Time frame: Change from baseline to 12 months, measured during 1 week prior to the visits
The C-PPAC is a validated and reliable hybrid tool combining a short patient-reported outcome questionnaire and two activity monitor variables (assessed by the accelerometer ActiGraph®) to measure physical activity in COPD patients in the two domains amount and difficulty (item scores 0-4, scale 0-100)
Time frame: Change from baseline to 12 months
The CAT measures the impact of COPD on a person's health status (8 questions, 6-point Likert-type scale)
Time frame: Change from baseline to 12 months
Symptoms of depression and anxiety (14 questions, 4-point Likert-type scale)
Time frame: Change from baseline to 12 months
The FT is a visual analogue scale for overall health state ranging from 0 (worst health you can imagine) to 100 (best healthy you can imagine)
Time frame: Change from baseline to 12 months
The EQ-5D-5L assesses the 5 dimensions mobility, self-care, usual activities, pain/discomfort, anxiety/depression including 1 item with 5 levels each
Time frame: During the entire study, assessed at 3, 6 and 12 months
The event-based definition required an increase in symptoms and an increase in dosage of or new prescription of systemic corticosteroids and/or antibiotics
Time frame: Assessed daily by intervention group participants during 12 months
Percentage of fulfilled training sessions based on training diaries
Time frame: From baseline to 12 months, assessed at 12 months
Self-developed questionnaire assessing satisfaction with the intervention: 10 specific questions regarding elements of the intervention using Likert-type scales from 0=not useful at all to 10=very useful) and 4 global questions using Likert-type scales (from 0=worst outcome to 4=best outcome)
Time frame: From baseline to 12 months, assessed at 12 months
Semi-structured interview and/or focus groups
Time frame: From baseline to 12 months, assessed at 12 months
Semi-structured interview and/or focus groups
Time frame: From baseline to 12 months, assessed at 3, 6 and 12 months
Questionnaire: Cost per quality-adjusted life-year, direct healthcare costs, direct non-healthcare costs, indirect costs
University of Zurich
Other
Effects of a Long-term Home-based Exercise Training Program Using Minimal Equipment vs Usual Care in COPD Patients: A Multicenter Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05696730
Behavior, Chronic Disease
Zurich, Switzerland
View Trial DetailsNCT03461887
Behavior, Chronic Disease
Barmelweid, Switzerland
View Trial DetailsNCT05780099
Cardiovascular Diseases, Chronic Disease
Milan, Italy
View Trial DetailsNCT07649577
Asthma, Bronchial Diseases
Amman, Jordan
View Trial Details